533 (Carbamazepine 200 mg)
Pill imprint 533 has been identified as Carbamazepine 200 mg.
Carbamazepine is used in the treatment of trigeminal neuralgia; bipolar disorder; schizoaffective disorder; epilepsy; borderline personality disorder (and more), and belongs to the drug class dibenzazepine anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Carbamazepine 200 mg is not a controlled substance under the Controlled Substance Act (CSA).
- 200 mg
- 14.00 mm
- Elliptical / Oval
- Prescription only
- Drug Class:
- Dibenzazepine anticonvulsants
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Caraco Pharmaceutical Laboratories
- National Drug Code (NDC):
- Inactive Ingredients:
- silicon dioxide colloidal
FD&C Red No. 40 Aluminium Lake
sodium starch glycolate
Note: Inactive ingredients may vary.
|NDC Code||Manufacturer / Repackager|
|13668-0268||Torrent Pharmaceuticals Limited|
More about carbamazepine
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 231 Reviews – Add your own review/rating
- Drug class: dibenzazepine anticonvulsants
- Carbamazepine chewable tablets
- Carbamazepine suspension
- Carbamazepine sustained-release capsules
- Carbamazepine sustained-release tablets
- More... (2)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.